补肾健脾方对乳腺癌CE(A)T化疗所致白细胞减少症的影响被引量：9

下载PDF

导出

摘要目的:探讨补肾健脾方对乳腺癌CE(A)T化疗所致白细胞减少症的影响,寻找改善白细胞减少症更稳定、安全而有效的方法。方法:采用随机对照研究方式,将30例患者随机分为2组,每组各15例。治疗组:CE(A)T化疗+中药治疗±欣粒生;对照组:CE(A)T化疗±欣粒生。两组病人化疗各疗程的第7天、第14天及第20天检测白细胞计数。1个化疗周期(即21天)为1个疗程。结果:与对照组相比,治疗组能够提高患者白细胞计数,有效缓解CE(A)T化疗相关白细胞减少症,降低发热机会及减少rhG-CSF应用,具有统计学差异。结论:补肾健脾方是治疗乳腺癌CE(A)T化疗所致白细胞减少症有效方法。

作者黄梅赖米林李本珊

机构地区广州中医药大学第一附属医院广东省中医院

出处《辽宁中医杂志》 CAS 北大核心 2011年第6期1140-1141,共2页 Liaoning Journal of Traditional Chinese Medicine

关键词乳腺癌化疗白细胞减少症中医辨证分型

分类号 R737.9 [医药卫生—肿瘤]

引文网络
相关文献

参考文献4

1Nabbohz JM, Canin J, CHANG J, et al. Phase III trial comparing granulcvyte colony - stimulating fator to leridistim in the prevention of neutropenic complications in breast cancer patients treated with docetaxel/ doxorubicin/cyclophosphamide : results of BCIRG004 trial [ J ]. Clin Breast Cancer,2002,3:268.
2张之南,沈悌.血液病诊断及疗效标准[M].北京:科学出版社,2008.103-122,131-134,172-176.
3吴涛,倪多,朱丽萍,欧江华.乳腺癌术后化疗方案TAC与AC→T近期不良反应比较[J].新疆医科大学学报,2009,32(12):1712-1714. 被引量：8
4张维丰.基因重组人粒细胞集落刺激因子防治肿瘤化疗反应92例[J].中国药业,2006,15(3):65-66. 被引量：3

二级参考文献10

1石远凯,周际昌,冯奉仪,曾万勇,李青,何小慧,张弘刚,张湘茹,周立强.基因重组人粒细胞集落刺激因子对肿瘤化疗所致白细胞减少的临床疗效观察[J].中华肿瘤杂志,1994,16(3):207-210. 被引量：35
2陈书长,张之南,刘沛新,郭小清,毋永娟.单纯化疗与并用粒细胞集落刺激因子对白血病患者的疗效比较[J].中华内科杂志,1996,35(4):249-252. 被引量：4
3Edith A, Perez MD. TAC-A new standard in adjuvant therapy for breast cancer? [J]. Cancer Res, 2009,69:597-603.
4Eiermann W, Pienkowski T , Crown J, et al. A phase Ⅲ randomized trial comparing docetaxel in combination with doxorubiein and cyclophosphamide (TAC) versus doxorubicin and cyclophosphamide followed by docetaxel (ACT) in women with Her 2/neu negative axillary lymph node positive early breast cancer[J]. Cancer Res, 2009,77:1158 -1161.
5Latifzadeh SZ,Salimi M, Naghnaeian M,et al. Dose dense(DD) two weekly docetaxel/doxorubicin/eyclopbosphamide (TAC) with G CSF support compared to standard adjuvant TAC in breast cancer patients[J]. Clin Oncol, 2008,26:628-632.
6Eiermann W, Pienkowski T, Crown J, et al. BCIRG 005 main efficacy analysis: a phase Ⅲ randomized trial comparing do cetaxel in combination with doxorubicin and cyclophosphamide (TAC) versus doxorubiein and eyelophosphamlde followed by docetaxel (ACT) in women with Her-2/neu negative axillary lymph node positive early breast cancer [J]. Cancer Res, 2009,69-77.
7Souza LM,Boone TC,Gabrilove J,et al.Recombinant human granulocyte colony-stimulating factor:effects on normal and leukemicmyeloid cells[J].Science.1986,232(4 746):61 -65.
8METCALFD.The role of the colong-stimulating factors in resistance to acute infections[J].Immunol Cell Biol,1987,65 (1):35-43.
9冯继锋,吴剑秋,郑秀立,黄富麟.惠尔血预防40例恶性肿瘤化疗后粒细胞减少症的临床观察[J].实用癌症杂志,1999,14(1):72-72. 被引量：11
10冯奉仪,张湘茹.重组人粒细胞集落刺激因子预防化疗后粒细胞减少的Ⅱ期临床试验[J].中国新药与临床杂志,1999,18(3):153-155. 被引量：13